HomeCannabisMariMed To Launch Award-Winning Brands in Michigan Adult-Use Cannabis Market

MariMed To Launch Award-Winning Brands in Michigan Adult-Use Cannabis Market

Published on

NORWOOD, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) —

MariMed, Inc

(CSE: MRMD), (OTCQX: MRMD), (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced an agreement with 42 Degrees, a Michigan licensed cannabis producer and distributer, to manufacture and distribute MariMed’s award-winning brands and products in the state. 42 Degrees currently wholesales products into 340 dispensaries, representing approximately 75 percent of the operating dispensaries in Michigan. The agreement provides initially for the manufacture, sales, and distribution of MariMed’s

Betty’s Eddies

full-spectrum fruit chews into the adult-use market. The intention longer-term is to roll out other brands in MariMed’s portfolio, including

Bubby’s Baked

soft and chewy baked goods and

Vibations: High + Energy

powder energy drink mix.

The licensing deal is aligned with the Company’s strategic growth plan to distribute its brands in legal cannabis states across the country. The Company anticipates

Betty’s Eddies

will be available in the Michigan retail market in early 2023.

“We are thrilled to partner with 42 Degrees for the production and distribution of our award-winning

Betty’s Eddies

branded products in the Michigan adult-use cannabis market,” said Ryan Crandall, Chief Revenue Officer for MariMed. “Michigan is one of the largest cannabis markets in the country and we could not be more pleased to introduce our brands to these great cannabis consumers within the state.”

According to the Michigan’s Cannabis Regulatory Agency, Michigan reported approximately $1.8 billion in total legal cannabis sales in 2021, which was up about 80% versus 2020. With a population of over 10 million and $1.8 billion in legal cannabis sales, Michigan is one of the largest, fastest-growing cannabis markets in the U.S. The adult-use cannabis market in Michigan is projected to grow to $2.1 billion dollars in 2025 according to Cowen Research.


About MariMed


MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including

Betty’s Eddies, Nature’s Heritage, Bubby’s Baked, K Fusion, Kalm Fusion

, and

Vibations: High + Energy

. For additional information, visit

www.marimedinc.com

.


For Questions Contact

:


Investors Relations

:

Steve West

Vice President, Investor Relations

Email:

[email protected]


Phone: (781) 277-0007


Company Contact:


Howard Schacter

Chief Communications Officer

Email:

[email protected]


Phone: (781) 277-0007


Media Contact:


Trailblaze PR

Email:

[email protected]

MariMed To Launch Award-Winning Brands in Michigan Adult-Use Cannabis Market


Primary Logo

Featured image: Megapixl © Lekjorruang

Disclaimer

Latest News

Cannabis companies are thriving as a result of Europe’s call for medical marijuana

A South African manufacturer has sold all of its output for the upcoming year...

Flora Growth Completes Multiple Commercial Cannabis Exports Into New International Markets

Flora (NASDAQ:FLGC) completed dry cannabis flower commercial exports to Switzerland and the Czech...

Global Hemp Fiber Market Rising at an Annual Rate of 6.9%

Las Vegas, NV, Sept. 22, 2022 (GLOBE NEWSWIRE) -- ...

Tilray Brands, Inc. to Announce First Quarter Fiscal 2023 Financial Results on October 7, 2022

NEW YORK and LEAMINGTON, Ontario, Sept. 23, 2022 (GLOBE...

More like this

Skye Bioscience Completes Drug Production for Phase 1 Clinical Study

San Diego, California, Sept. 20, 2022 (GLOBE NEWSWIRE) --...

VIVO Cannabis Announces Agreement to Amend Outstanding Debentures

Toronto, Ontario--(Newsfile Corp. - September 19, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX:...

High Tide Closes $19 Million Non-Dilutive Credit Facility with connectFirst Credit Union

High Tide Closes $19 Million Non-Dilutive Credit Facility...